Kidney Research and Clinical Practice

Search

Page Path

HOME
Search

Case Reports

Cardiac arrest caused by nafamostat mesilate: Hyo Shik Kim, Kyung Eun Lee, Ji Hyun Oh et al.; Kidney Res Clin Pract. 2016;35(3):187-189. Published online November 12, 2015; DOI: https://doi.org/10.1016/j.krcp.2015.10.003
Web of Science 25 Cited By 27; Full text PubReader PDF

Low-Dose Nafamostat Mesilate in Hemodialysis Patients at High Bleeding Risk: Eun Yi Kim Young-Ki Lee, Seung Min Lee, Myung-Jin Choi, Young Rim Song, Soo Jin Kim, Tae Jin Park, Sung Gyun Kim, Jieun Oh, Jang Won Seo, Jong-Woo Yoon, Ja-Ryong Koo, Hyung Jik Kim and Jung-Woo Noh; Korean J Nephrol. 2011;30(1):61-66.; PDF

Saline Versus Nafamostat Mesilate Anticoagulation for Continuous Veno-venous Hemofiltration (CVVH) in Patients at High Risk of Bleeding: A Prospective Study: In-Il Park, M.D., Myung-Jin Choi, M.D., Jong-Woo Yoon, M.D., Young-Ki Lee, M.D., Sung-Gyun Kim, M.D., Ji-Eun Oh, M.D., Jang-Won Seo, M.D., Hyung-Jik Kim, M.D., Jung-Woo Noh, M.D. and Ja-Ryong Koo, M.D.; Korean J Nephrol. 2009;28(3):205-210.; PDF

Volume 43, No. 2

Kidney Research
and
Clinical Practice

Print ISSN: 2211-9132
Online ISSN: 2211-9140

Impact Factor

3.0

MOST VIEWED MOST CITED

15,095	Validation of operational definitions of mortality in a nationwide hemodialysis population using the Health Insurance Review and Assessment Service databases of Korea
20,010	C4d Puzzle in ABO-incompatible kidney transplantation
8,515	How should we treat acute kidney injury caused by renal congestion?
13,238	Management of autosomal dominant polycystic kidney disease in the era of disease-modifying treatment options
35,336	Uremic pruritus: pathophysiology, clinical presentation, and treatments

Cited By 15	Association between blood pressure and the risk of chronic kidney disease in treatment-naïve hypertensive patients
Cited By 13	Exploring molecular targets in diabetic kidney disease
Cited By 13	Application of C5 inhibitors in glomerular diseases in 2021
Cited By 13	GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
Cited By 11	Prostaglandin E2 receptors as therapeutic targets in renal fibrosis

Editorial Office: #301, (Miseung Bldg.) 23, Apgujenog-ro 30-gil, Gangnam-gu, Seoul 06022, Korea
Tel: +82-2-3486-8736 Fax: +82-2-3486-8737 E-mail: registry@ksn.or.kr

Copyright © 2024 by The Korean Society of Nephrology.